Invivyd expands COVID-19 study, develops measles antibody candidate

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. INTC
2. DSX
3. GNK
4. III
5. TTEC
6. DAL
7. AWK
8. SPCX
9. AMIX
10. Z

Go back to Invivyd expands COVID-19 study, develops measles antibody candidate
(NASDAQ: IVVD) Delayed: 0.97 +0.04 (4.30%)
Previous Close $0.93    52 Week High $ 
Open $0.94    52 Week Low $ 
Day High $1.01    P/E N/A 
Day Low $0.90    EPS $ 
Volume 21,078,806